Delivery Order 36F79721D0249-36C24826F0037
Award Date 10/22/25
Potential Completion Date 11/22/25
Potential Value $124K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
KNG OF PRUSSA, PA 19406, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., doing business as CSL Behring LLC, a global biotherapeutics company. The $154,935.10 firm fixed price delivery order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract managed by the General Services Administration. The contract is for the supply of the Hereditary Angioedema treatment HAEGARDA and the intravenous...
- This is a delivery order awarded by the Veterans Integrated Service Network 8 (VISN 8), part of the U.S. Department of Veterans Affairs (VA), to CSL Behring L.L.C. The contract, which has a ceiling value of $87,207.54, is for the procurement of HAEGARDA, a C1 inhibitor medication used to treat hereditary angioedema. The delivery order was issued under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a larger ceiling value of...
- The Department of Veterans Affairs Veterans Health Administration, through its Veterans Integrated Service Network 22, awarded a $153,282.20 firm fixed-price delivery order to CSL Behring L.L.C. for the Hereditary Angioedema treatment HAEGARDA. This order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration, which allows federal agencies to efficiently procure pharmaceuticals through task orders. The contract has...
- This is a federal contract award to CSL Behring L.L.C., a global biotherapeutics company, for the delivery of the Hereditary Angioedema treatment HAEGARDA to the Department of Veterans Affairs (VA) and its regional Veterans Integrated Service Networks (VISNs). The $104,510.10 firm fixed price award was issued against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract managed by the General Services Administration (GSA), allowing VA medical centers and other federal agencies...
- This is a federal contract award made by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., doing business as CSL Behring LLC, for the delivery of HAEGARDA, a pharmaceutical product used to treat Hereditary Angioedema. The $117,027.68 firm fixed price delivery order was issued against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration (GSA). The contract has no set-aside designation and...
- This federal contract award to CSL Behring L.L.C., doing business as CSL Behring LLC, is for the delivery of HAEGARDA medication to the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 7. The $104,510.10 firm fixed price delivery order was issued against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration (GSA). The contract has no set-aside designation. CSL Behring, a global...
- This is a delivery order awarded by the Veterans Integrated Service Network 8 (VISN 8), a division of the U.S. Department of Veterans Affairs (VA), to CSL Behring L.L.C. for the supply of 72 units of the pharmaceutical product HAEGARDA (a C1 inhibitor for hereditary angioedema). The contract has a firm fixed price of $87,207.54 and an ultimate completion date of April 28, 2021. This delivery order was placed against CSL Behring's primary Federal Supply Schedule contract for Pharmaceuticals and...
- This federal contract award is for the delivery of HAEGARDA, a treatment for Hereditary Angioedema, to the Department of Veterans Affairs (VA) Veterans Health Administration. The $119,814.22 firm fixed price delivery order was issued against CSL Behring LLC's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration (GSA). This contract allows the VA and other agencies to efficiently procure pharmaceutical products through task orders. The award has no...
- The Department of Veterans Affairs Veterans Health Administration (VA) awarded a $103,256.12 firm fixed price delivery order to CSL Behring L.L.C. for the supply of HAEGARDA, a C1 inhibitor (human) injection solution, to the VA's Veterans Integrated Service Network 8. This order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract with the General Services Administration and the VA. The order has a completion date of December 31, 2018 and did not have...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 7 to the prime contractor CSL Behring L.L.C., doing business as CSL Behring LLC. The contract is a Delivery Order against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration, with a firm fixed price of $103,831.50 and no set-aside designation. The award is for the supply of HAEGARDA...